In October 2014, Triangle Biosystems was acquired by SBIR involved firm Harvard Biosciences (NASDAQ:HBIO). Triangle BioSystems International develops wireless neurological research equipment for brain and nerve monitoring, recording and stimulation. The firm's advanced neuro-technology hardware and software enables the acquisition of action potential signals (spikes) from individual brain cells (neurons), as well as low frequency field potential (LFP and EEG) signals in wireless and miniature tethered packages. Systems are designed to work with rodents and primates for biological, medical, psychological studies, and pharmaceutical drug discovery. TBSI's proprietary, stand alone software and hardware solutions are available in many configurations that can be uniquely adapted to interface with other application software. Technology is also compatible with a variety of data acquisition products already available in the industry. The company is considered the global leader in wireless neural recording and stimulation.
